Description
Enoxaparin Solution for Injections 10000 anti-Cha IU/ml. 0.4 ml Syringe
Ingredients
Enoxaparin solution for injections contains 10000 anti-Cha IU/ml as the active ingredient. Other ingredients may include water for injection, sodium chloride, and benzyl alcohol.
Mechanism of Action
Enoxaparin, a low molecular weight heparin, inhibits the formation of blood clots by enhancing the inhibition of factor Xa and thrombin, crucial components in the coagulation cascade.
Pharmacological Properties
Enoxaparin acts by preventing the formation of blood clots, making it effective in the prevention and treatment of thrombotic events.
Indications for Use
Enoxaparin is indicated for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and for reducing the risk of blood clots in patients undergoing specific surgical procedures.
Contraindications
This medication is contraindicated in patients with active major bleeding, hypersensitivity to Enoxaparin, and in conditions such as bacterial endocarditis where its use may be harmful.
Side Effects
Common side effects of Enoxaparin may include bruising, bleeding, or injection site reactions. Contact your healthcare provider if you experience any unusual symptoms.
Usage Instructions
Enoxaparin is typically administered subcutaneously once or twice daily as directed by a healthcare professional. Administer the injection into the abdomen, avoiding areas with scars or bruising, and refrain from rubbing the injection site after administration.
Benefits Compared to Analogues
Studies have shown that Enoxaparin is as effective as other anticoagulants with potentially fewer side effects, making it a favorable choice for thromboprophylaxis.
Suitable Patient Groups
Enoxaparin can be used in various patient populations, including children and elderly individuals, under appropriate medical supervision.
Storage and Shelf Life
Store Enoxaparin according to the manufacturer’s instructions, typically at controlled room temperature. Check the expiration date on the packaging and do not use expired medication.
Packaging Description
Enoxaparin solution for injections is available in prefilled syringes containing 0.4 ml of the solution, each labeled with the concentration and dosage strength.
Scientific Evidence
Studies have demonstrated the efficacy of Enoxaparin in preventing and treating blood clots. Research published in reputable journals has highlighted its effectiveness in reducing the risk of venous thromboembolism in surgical patients.
Clinical Trials
Clinical trials comparing Enoxaparin with other anticoagulants have shown similar efficacy with potentially improved safety profiles. Research in the Journal of Thrombosis and Haemostasis supports the effectiveness of Enoxaparin in preventing deep vein thrombosis.
Additional Information
It is crucial to monitor for signs of bleeding while on Enoxaparin therapy. Report any unusual bleeding or bruising to your healthcare provider promptly for further evaluation.
